Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2719 results

Sort By:

Neuroinflammation in Asymptomatic Carotid Artery Disease - Imaging Substudy

Study ID: NCT05238961
Start Date: 2026-04-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

[18F]DPA-714

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

The Prevalence, Disease Burden and Prognosis of COPD in Patients With Cardiovascular Diseases

Study ID: NCT06909773
Start Date: 2025-11-30
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

3000

Intervention / Treatment

Guideline education and implementation intervention

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma

Study ID: NCT07093554
Start Date: 2025-12-01
End Date: 2028-01-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

31

Intervention / Treatment

Talquetamab

Ciltacabtagene Autoleucel

Sponsor

Medical College of Wisconsin

Source: clinicaltrials.gov

Share:
Add to list

Dental-Child Interaction Training

Study ID: NCT06138405
Start Date: 2026-01-15
End Date: 2029-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

264

Intervention / Treatment

Immediate intervention Group

Delayed intervention (control) Group

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial

Study ID: NCT06974370
Start Date: 2025-12
End Date: 2030-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

45

Intervention / Treatment

Active Surveillance

Sponsor

University of Vermont Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma

Study ID: NCT05039892
Start Date: 2026-12
End Date: 2028-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

3D 185

Sponsor

3D Medicines (Beijing) Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

What is the Prognostic Value of HALP Score, Monocytopenia, Hypofibrinogenemia, and AST/ALT Ratio in Patients With Myelodysplastic Syndromes

Study ID: NCT07210034
Start Date: 2026-01-01
End Date: 2028-03-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment
Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Can Exercise Rewire the Brain Addiction Circuitry?

Study ID: NCT06317753
Start Date: 2026-01
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Aerobic Exercise

Agility-Cognitive Exercise

Stretching/relaxation

Sponsor

University of Minho

Source: clinicaltrials.gov

Share:
Add to list

Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone

Study ID: NCT06833411
Start Date: 2026-01
End Date: 2032-08
Study Type

Interventional

Study Phase

Phase3

No. of Participants

178

Intervention / Treatment

Prednisone

Prednisone

Sponsor

Insel Group AG, University Hospital Bern

Source: clinicaltrials.gov

Share:
Add to list

Personalized IoT-based Physical Activity Monitoring System for Heart Failure Patients

Study ID: NCT07171372
Start Date: 2025-12-13
End Date: 2027-03-13
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

82

Intervention / Treatment

Device&behavioral

Sponsor

Abant Izzet Baysal University

Source: clinicaltrials.gov

Share:
Add to list